Raffles Medical Group Ltd

OTCPK:RAFL.F Stock Report

Market Cap: US$1.3b

Raffles Medical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:RAFL.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Mar 25SellUS$3,301,681Global Alpha Capital Management Ltd.Company4,438,000US$0.74
03 Feb 25SellUS$87,278Global Alpha Capital Management Ltd.Company142,600US$0.61
31 Jan 25BuyUS$5,755Global Alpha Capital Management Ltd.Company12,000US$0.48
28 Jan 25SellUS$9,123Global Alpha Capital Management Ltd.Company20,000US$0.46
27 Nov 24BuyUS$446,112Choon Yong LooIndividual700,000US$0.64
26 Nov 24BuyUS$446,492Choon Yong LooIndividual700,000US$0.64
22 Nov 24BuyUS$637,948Choon Yong LooIndividual1,000,000US$0.64
18 Nov 24BuyUS$96,719Choon Yong LooIndividual150,000US$0.64
11 Nov 24BuyUS$983,942Choon Yong LooIndividual1,500,000US$0.66
07 Nov 24SellUS$117,542Global Alpha Capital Management Ltd.Company175,800US$0.67
30 Oct 24BuyUS$669,314Choon Yong LooIndividual1,000,000US$0.67
29 Oct 24BuyUS$738,536Choon Yong LooIndividual1,100,000US$0.67
26 Sep 24BuyUS$325,498Choon Yong LooIndividual470,000US$0.69
25 Sep 24BuyUS$0.45Choon Yong LooIndividual450,000US$0.000001
24 Sep 24BuyUS$1,176,495Choon Yong LooIndividual1,700,000US$0.69
12 Aug 24BuyUS$528,649Choon Yong LooIndividual800,000US$0.66
06 Aug 24BuyUS$407,332Choon Yong LooIndividual600,000US$0.68
05 Aug 24BuyUS$549,564Choon Yong LooIndividual800,000US$0.69
02 Aug 24BuyUS$557,978Choon Yong LooIndividual800,000US$0.70
01 Aug 24BuyUS$984,131Choon Yong LooIndividual1,400,000US$0.70
31 Jul 24BuyUS$177,565S & D Holdings Pte LtdCompany250,000US$0.71
27 Jun 24BuyUS$577,574Choon Yong LooIndividual800,000US$0.72
26 Jun 24BuyUS$1,087,365Choon Yong LooIndividual1,500,000US$0.72
21 Jun 24BuyUS$737,806Choon Yong LooIndividual1,000,000US$0.74
20 Jun 24BuyUS$590,850Choon Yong LooIndividual800,000US$0.74
19 Jun 24BuyUS$1,111,962Choon Yong LooIndividual1,500,000US$0.74
18 Jun 24BuyUS$373,554Choon Yong LooIndividual500,000US$0.75
14 Jun 24BuyUS$373,093Choon Yong LooIndividual500,000US$0.75
13 Jun 24BuyUS$148,185Choon Yong LooIndividual200,000US$0.74
12 Jun 24BuyUS$607,034Choon Yong LooIndividual800,000US$0.76
11 Jun 24BuyUS$753,379Choon Yong LooIndividual1,000,000US$0.75
10 Jun 24BuyUS$376,826Choon Yong LooIndividual500,000US$0.75
06 Jun 24BuyUS$606,061Choon Yong LooIndividual800,000US$0.76
05 Jun 24BuyUS$756,273Choon Yong LooIndividual1,000,000US$0.76
03 Jun 24BuyUS$302,882Choon Yong LooIndividual400,000US$0.76
31 May 24BuyUS$679,045Choon Yong LooIndividual900,000US$0.75
29 May 24BuyUS$532,799Choon Yong LooIndividual700,000US$0.76
27 May 24BuyUS$305,499Choon Yong LooIndividual400,000US$0.76
24 May 24BuyUS$228,955Choon Yong LooIndividual300,000US$0.76
23 May 24BuyUS$114,451Choon Yong LooIndividual150,000US$0.76
20 May 24BuyUS$382,283Choon Yong LooIndividual500,000US$0.76
17 May 24BuyUS$758,398Choon Yong LooIndividual1,000,000US$0.76
16 May 24BuyUS$457,756Choon Yong LooIndividual600,000US$0.76
15 May 24BuyUS$535,785Choon Yong LooIndividual700,000US$0.77
14 May 24BuyUS$377,211Choon Yong LooIndividual500,000US$0.75
13 May 24BuyUS$75,352Choon Yong LooIndividual100,000US$0.75
09 May 24BuyUS$761,007Choon Yong LooIndividual1,000,000US$0.76

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RAFL.F?
Owner TypeNumber of SharesOwnership Percentage
Institutions262,242,94414.2%
Individual Insiders282,638,31915.3%
General Public524,704,79228.3%
Private Companies782,149,87042.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 71.47% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
38.9%
Raffles Medical Holdings Pte. Ltd.
719,394,504US$522.4m0%no data
13.5%
Choon Yong Loo
250,684,532US$182.0m-0.23%no data
7.77%
Global Alpha Capital Management Ltd.
143,874,113US$104.5m-13.9%3.32%
3.39%
S & D Holdings Pte Ltd
62,755,366US$45.6m-0.4%no data
1.88%
The Vanguard Group, Inc.
34,791,007US$25.3m1.12%no data
0.87%
Thomas Lee
16,123,192US$11.7m1.9%no data
0.82%
Norges Bank Investment Management
15,259,794US$11.1m0%no data
0.78%
Asian Medical Foundation Ltd., Endowment Arm
14,443,321US$10.5m0%no data
0.71%
BlackRock, Inc.
13,166,414US$9.6m-0.77%no data
0.55%
Hee Seng Yii
10,120,513US$7.3m0.9%no data
0.53%
Dimensional Fund Advisors LP
9,800,593US$7.1m-1.16%no data
0.37%
Ifast Financial Pte. Ltd., Asset Management Arm
6,821,621US$5.0m67.1%0.51%
0.26%
Bessemer Investment Management LLC
4,870,449US$3.5m0%0.01%
0.25%
Soo Nan Tan
4,671,000US$3.4m0%no data
0.12%
Fidelity International Ltd
2,289,300US$1.7m0%no data
0.12%
Wellington Management Group LLP
2,182,700US$1.6m0%no data
0.1%
Manulife Asset Management
1,844,100US$1.3m-68.2%no data
0.094%
American Century Investment Management Inc
1,739,402US$1.3m0%no data
0.094%
Impax Asset Management Group Plc
1,732,100US$1.3m0%no data
0.092%
Charles Schwab Investment Management, Inc.
1,695,795US$1.2m-3.34%no data
0.087%
UBS Asset Management AG
1,618,184US$1.2m47.7%no data
0.079%
Nordea Investment Management, AB
1,471,500US$1.1m0%no data
0.037%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
688,099US$499.7k0%no data
0.037%
State Street Global Advisors, Inc.
683,289US$496.2k-7.73%no data
0.036%
Geode Capital Management, LLC
663,307US$481.6k2.64%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/15 18:01
End of Day Share Price 2025/01/16 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Raffles Medical Group Ltd is covered by 21 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MakCGS International
Patrick YauCitigroup Inc
null nullCLSA